World

How 23andMe Went From $6B Valuation to Penny Stock | WSJ What Went Wrong

DNA-testing company 23AndMe and its founder, Anne Wojcicki, aimed to revolutionize healthcare, bringing genetic tests to homes with just a tube of spit. But challenges with its business model and continued data privacy concerns for consumers have brought the company once valued at $6 billion to a valuation of nearly $0, with Nasdaq threatening to delist it. WSJ explains what went wrong with Wojcicki’s biotech business. 0:00 Home DNA testing 0:49 The rise of 23andMe 2:18 The turning point 4:03 23andMe’s fall 5:23 What’s next? What Went Wrong explores the challenging conditions and decisions that led to a company s downturn. #23andMe #DNA #WSJ :::: Visit my YouTube channel @ The Wall Street Journal ( [ 🔗 Click ‼️ ]] )


( 100 Page ) :: 🏠 87 88 89 90 91 92 93 94 95 96 97 ▶️ ⭕️


🌟   12     BULGARIA - First Walk Around SUNNY BEACH


🌟   9     PACKING FOR DREAM TRIP ABROAD! ✈️


🌟   7     The Exciting Boat Trip Adventure #Shorts #PeppaPig #LEGODUPLO


🌟   5     ਪੰਜਾਬ ਤੋਂ ਲੁੱਟਿਆ ਹੋਇਆ ਕੋਹਿਨੂਰ ਹੀਰਾ Kohinoor London Museum | Punjabi Travel Couple


🌟   4     trip to Байкал. Граница льда и воды #байкал #trip #рекомендации

( 100 Page ) :: 🏠 87 88 89 90 91 92 93 94 95 96 97 ▶️ ⭕️







2024 World of flash-mini.com : About us

Contacts email : [email protected]

The content on this page is generated and generated by social media content automatically. If you encounter a problem or want to delete the information Please inform at this email >> [email protected]

This website uses cookies or similar technologies, to enhance your browsing experience and provide personalized recommendations. By continuing to use our website, you agree to our Privacy Policy & Terms